On 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has ...

The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...

A new study published in the journal of Nature Scientific Reports found that anemia was almost three times as common in women ...

For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and ...

We recently published a list of 10 Best Nasdaq Stocks Under $5 to Buy. In this article, we are going to take a look at where Arbutus Biopharma Corp. (NASDAQ:ABUS) stands against other best Nasdaq ...

The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

Proceeds expected to fund the start of the ALG-000184 Phase 2 clinical studyFunding expected to extend cash runway into the second half of ...